Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Joshi

Showing results (411-420 of 455) with videos related to

Pageof 46
Sort By:
The Lancet. Oncology|January 22, 2026
Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trialLisa M Wintner, Monika Sztankay, Hikmat Abdel-Razeq, et al.
Frontiers in Oncology|October 9, 2023
Response assessment of post-treatment head and neck cancers to determine further management using NI-RADS (Neck Imaging Reporting and Data System): a subgroup analysis of a randomized controlled trialAbhishek Mahajan, Himangi Unde, Nilesh P Sable, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|May 20, 2020
Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern eraSarbani Ghosh-Laskar, Avinash Pilar, Carlton Johnny, et al.
Breast Cancer Research and Treatment|June 2, 2017
Host genetic modifiers of nonproductive angiogenesis inhibit breast cancerMichael J Flister, Shirng-Wern Tsaih, Alexander Stoddard, et al.
Frontiers in Oncology|June 20, 2022
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent ChemoradiotherapyAbhishek Mahajan, Ankur Chand, Ujjwal Agarwal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2023
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavitySarbani G Laskar, Devendra Chaukar, Mandar Deshpande, et al.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral CancerVijay M Patil, Vanita Noronha, Amit Joshi, et al.
Head & Neck|March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysisSarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
Oncotarget|February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancerVanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Pageof 46

Showing results (411-420 of 455) with videos related to

Sort By:
Pageof 46
The Lancet. Oncology|January 22, 2026
Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trialLisa M Wintner, Monika Sztankay, Hikmat Abdel-Razeq, et al.
Frontiers in Oncology|October 9, 2023
Response assessment of post-treatment head and neck cancers to determine further management using NI-RADS (Neck Imaging Reporting and Data System): a subgroup analysis of a randomized controlled trialAbhishek Mahajan, Himangi Unde, Nilesh P Sable, et al.
World Journal of Otorhinolaryngology - Head and Neck Surgery|May 20, 2020
Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane-based induction chemotherapy and concurrent chemo-radiotherapy in the modern eraSarbani Ghosh-Laskar, Avinash Pilar, Carlton Johnny, et al.
Breast Cancer Research and Treatment|June 2, 2017
Host genetic modifiers of nonproductive angiogenesis inhibit breast cancerMichael J Flister, Shirng-Wern Tsaih, Alexander Stoddard, et al.
Frontiers in Oncology|June 20, 2022
Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent ChemoradiotherapyAbhishek Mahajan, Ankur Chand, Ujjwal Agarwal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2023
Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavitySarbani G Laskar, Devendra Chaukar, Mandar Deshpande, et al.
Breast Cancer Research and Treatment|June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcomeCody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral CancerVijay M Patil, Vanita Noronha, Amit Joshi, et al.
Head & Neck|March 13, 2023
Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysisSarbani Ghosh Laskar, Shwetabh Sinha, Meetakshi Gupta, et al.
Oncotarget|February 18, 2020
Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancerVanita Noronha, Vijay Maruti Patil, Amit Joshi, et al.
Pageof 46